biospecimen__admin__batch_number	425.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	74579587-C2E6-4E49-BEB5-7F23119C6099
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-AAE0-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-AAE0-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-AAE0-01A
biospecimen__bio__biospecimen_barcode_bottom	0174164335
biospecimen__bio__day_of_creation	09
biospecimen__bio__day_of_shipment	28
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	04
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-AAE0.C8EB705D-E9F9-4101-9B7F-EE4968CA5781.pdf
biospecimen__bio__plate_column	8
biospecimen__bio__plate_id	A41H
biospecimen__bio__plate_row	B
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-DD-AAE0
biospecimen__shared__patient_id	AAE0
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	BBFD0C0E-DB56-4D59-9837-907AF36FECF2
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	4.8
clinical__chol_lihc_shared__albumin_result_upper_limit	5.3
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.9
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.5
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	8751
clinical__chol_lihc_shared__fibrosis_ishak_score	3,4 - Fibrous Speta
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	1.0
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.0
clinical__chol_lihc_shared__platelet_result_lower_limit	130
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	45
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-AAE0-F68410
clinical__clin_shared__bcr_followup_uuid	30937D04-EFAD-4353-81FD-8B5180BA0187
clinical__clin_shared__day_of_form_completion	14
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	226
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G4
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3a
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	8620cc21-9ebe-4d9c-9499-6726c956848b
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-AAE0-01A-11R-A41H-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	270128ba-82e2-4c0f-b903-326d5902fbb6
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.85
gdc__analytes__analyte_id	8aeedfe4-923d-4d8d-b176-987c89d6ca4c
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	5e4136e4-ddd8-4faf-8a8e-5f836fd97f49
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:29:32.212662-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	3517cfd9-0068-5d49-b1ac-19fa85b12f74
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1968
gdc__diagnoses__age_at_diagnosis	16732
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-16732.0
gdc__diagnoses__days_to_last_follow_up	555.0
gdc__diagnoses__diagnosis_id	7062c598-f9bd-5242-be47-21ce5d50d10d
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	22.151022507021082
gdc__exposures__exposure_id	61f8c48d-87b7-559f-a1f2-2a73ad24546f
gdc__exposures__height	159.0
gdc__exposures__weight	56.0
gdc__file_id	03cd9e0d-b484-4cf6-929e-9b75970f22f9
gdc__file_name	5a5895ab-6690-4686-a918-9fce6858e69f.mirbase21.mirnas.quantification.txt
gdc__file_size	50492
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	0cd2c6e0f2958c2fcfaf0827c3dd9d57
gdc__portions__is_ffpe	false
gdc__portions__portion_id	f2bdfb2a-1903-4dd0-b7ba-34f2a3226199
gdc__portions__portion_number	11
gdc__portions__weight	20.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	314
gdc__samples__initial_weight	40.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	C8EB705D-E9F9-4101-9B7F-EE4968CA5781
gdc__samples__sample_id	29ef7722-025a-458b-aa60-1ca9c3e70ada
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	15.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	1.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	62.0
gdc__slides__percent_tumor_cells	37.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	d374ef1b-d342-405b-b553-28e96f46b93c
gdc__submitter_id	mirna_swap_dr11_32_MirnaExpression533d9d44-7a4f-4876-aadb-d36d4c6440be_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	13ba8d27-2a79-5d78-9c25-998ad6a1cb3e
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:51.645+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/8620cc21-9ebe-4d9c-9499-6726c956848b-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/8620cc21-9ebe-4d9c-9499-6726c956848b-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129863
manually_curated__local_md5	b5ddc875321f600ffee2c8c035ff6908
manually_curated__opengdc_download_date	2018-10-16T17:13:06.000407+02:00
manually_curated__opengdc_file_md5	92d986dbda459856c011a855e90b19b4
manually_curated__opengdc_file_size	50491
manually_curated__opengdc_id	8620cc21-9ebe-4d9c-9499-6726c956848b-meq
manually_curated__origin_file_size	129863
manually_curated__origin_last_modified_date	Tue Oct 16 17:30:00 CEST 2018
manually_curated__origin_md5	b5ddc875321f600ffee2c8c035ff6908
manually_curated__tissue_status	tumoral
